{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:46:52Z","timestamp":1790689612292,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/inf.0b013e318202cbb3","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T03:15:16Z","timestamp":1289963716000},"page":"375-378","source":"Crossref","is-referenced-by-count":104,"title":["Fluconazole Loading Dose Pharmacokinetics and Safety in Infants"],"prefix":"10.1097","volume":"30","author":[{"given":"Lauren","family":"Piper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph P.","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira M.","family":"Cheifetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cohen-Wolkowiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210202","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1542\/peds.112.3.634","article-title":"Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques.","volume":"112","author":"Benjamin","year":"2003","journal-title":"Pediatrics"},{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.clp.2006.09.005","article-title":"Infection in late preterm infants.","volume":"33","author":"Benjamin","year":"2006","journal-title":"Clin Perinatol"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.idc.2006.06.006","article-title":"Mycoses in pediatric patients.","volume":"20","author":"Steinbach","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"R7-5-20210202","article-title":"Diflucan [package insert].","year":"2008"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9343(98)00326-X","article-title":"A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.","volume":"105","author":"Malik","year":"1998","journal-title":"Am J Med"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9343(99)00457-X","article-title":"A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.","volume":"108","author":"Winston","year":"2000","journal-title":"Am J Med"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis.","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1128\/AAC.00741-06","article-title":"In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.","volume":"50","author":"Clancy","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-5-20210202","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1128\/AAC.49.8.3171-3177.2005","article-title":"Fluconazole MIC and the fluconazole dose\/MIC ratio correlate with therapeutic response among patients with candidemia.","volume":"49","author":"Clancy","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/INF.0b013e31819f1f50","article-title":"Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.","volume":"28","author":"Wade","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/AAC.00569-08","article-title":"Population pharmacokinetics of fluconazole in young infants.","volume":"52","author":"Wade","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.","volume":"30","author":"Rex","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/FTD.0b013e3181b20b40","article-title":"A rapid and sensitive LC-MS\/MS method for determination of fluconazole in human plasma and its application in infants with Candida infections.","volume":"31","author":"Wu","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R19-5-20210202","first-page":"447","article-title":"Treatment options of invasive fungal infections in adults.","volume":"136","author":"Fl\u00fcckiger","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s001340050286","article-title":"Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.","volume":"23","author":"Nolla-Salas","year":"1997","journal-title":"Intensive Care Med"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10096-004-1104-x","article-title":"Economic impact of Candida colonization and Candida infection in the critically ill patient.","volume":"23","author":"Olaechea","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R22-5-20210202","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","article-title":"Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.","volume":"233","author":"Pelz","year":"2001","journal-title":"Ann Surg"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/AAC.43.9.2116","article-title":"Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.","volume":"43","author":"Andes","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200342050-00001","article-title":"Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates.","volume":"42","author":"Buck","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"R26-5-20210202","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1128\/AAC.33.6.817","article-title":"Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation.","volume":"33","author":"Southgate","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-5-20210202","first-page":"711","article-title":"Vancomycin pharmacokinetics in infants undergoing extracorporeal membrane oxygenation.","volume":"9","author":"Hoie","year":"1990","journal-title":"Clin Pharm"},{"key":"R28-5-20210202","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/AAC.40.5.1139","article-title":"Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.","volume":"40","author":"Amaker","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-5-20210202","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/j.1875-9114.1998.tb03938.x","article-title":"Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.","volume":"18","author":"Buck","year":"1998","journal-title":"Pharmacotherapy"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.43.8.1955","article-title":"Safety and tolerability of fluconazole in children.","volume":"43","author":"Novelli","year":"1999","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e318202cbb3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:37:17Z","timestamp":1786041437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201105000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318202cbb3","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}